TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases (Q2866969): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in pt, en, fr, de, nl, it, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
||
label / pt | label / pt | ||
TERAPI1 .: Protecção dos direitos de Propriedade Intelectual de novos agentes terapêuticos contra doenças amilóides de transtirretina | |||
label / en | label / en | ||
TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases |
Revision as of 13:36, 25 August 2022
Project Q2866969 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases |
Project Q2866969 in Portugal |
Statements
24,384.0 Euro
0 references
48,769.0 Euro
0 references
50.0 percent
0 references
20 May 2017
0 references
19 May 2021
0 references
BSIM THERAPEUTICS, S.A.
0 references
Q2988326 (Deleted Item)
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-028007
0 references